ARTICLE

FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

By Yasemin Saplakoglu — 2019

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Read on www.livescience.com

FindCenter Post-Image

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...

FindCenter AddIcon
FindCenter Post-Image

What Psychedelic Mushrooms Are Teaching Us About Human Consciousness

Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.

FindCenter AddIcon

EXPLORE TOPIC

Psilocybin